Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Published on July 22, 2014 at 5:37 AM · No Comments

Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.

With a test result close to the gold standard (phlegm smear and germiculture), Chemclin's Anti-TB assay has a positive correlation to the existing commercial methods including a colloidal gold immunoassay which has been widely used in most of the hospitals and laboratories in China.

Tuberculosis is a chronically infectious disease caused by mycobacterium tuberculosis infection. The virus may live in the human body for a long time. Almost all tissues and organs may suffer from infection of mycobacterium tuberculosis and further break out tuberculosis. The diagnosis of tuberculosis must be based on full analysis of medical history, clinical symptoms and results from physical examination and laboratory tests, which can help make the diagnosis carefully.



Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Insights into immune system pathways may be key to developing effective TB vaccine